{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T11:46:24Z","timestamp":1782474384964,"version":"3.54.5"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["J Trauma Acute Care Surg"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Administration of antifibrinolytic medications, including tranexamic acid (TXA), may reduce head injury\u2013related mortality. The effect of these medications on post\u2013traumatic brain injury (TBI) inflammatory response is unknown. The goal of this study was to investigate the role of available antifibrinolytic medications on both systemic and cerebral inflammation after TBI.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>An established murine weight drop model was used to induce a moderate TBI. Mice were administered 1, 10, or 100 mg\/kg of TXA, 400 mg\/kg of aminocaproic acid (Amicar, Hospira, Lake Forest, IL), 100 kIU\/kg of aprotonin, or equivalent volume of normal saline (NS) 10 minutes after recovery. Mice were euthanized at 1, 6, or 24 hours. Serum and cerebral tissue were analyzed for neuron-specific enolase and inflammatory cytokines. Hippocampal histology was evaluated at 30 days for phosphorylated tau accumulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>One hour after TBI, mice given TXA displayed decreased cerebral cytokine concentrations of tumor necrosis factor \u03b1 (TNF-\u03b1) and, by 24 hours, displayed decreased concentrations of cerebral TNF-\u03b1, interleukin (IL)-6, and monocyte chemoattractant protein 1 compared with TBI-NS. However, serum concentrations of TNF-\u03b1 and macrophage inflammatory protein 1\u03b1 (MIP-1\u03b1) were significantly elevated from 1 to 24 hours in TBI-TXA groups compared with TBI-NS. The concentration of phosphorylated tau was significantly decreased in a dose-dependent manner in TBI-TXA groups compared with TBI-NS. By contrast, Amicar administration increased cerebral cytokine levels of IL-6 1 hour after TBI, with serum elevations noted in TNF-\u03b1, MIP-1\u03b1, and monocyte chemoattractant protein 1 at 24 hours compared with TBI-NS. Aprotonin administration increased serum TNF-\u03b1, IL-6, and MIP-1\u03b1 from 1 to 24 hours without differences in cerebral cytokines compared with TBI-NS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>Tranexamic acid administration may provide acute neuroinflammatory protection in a dose-dependent manner. Amicar administration may be detrimental after TBI with increased cerebral and systemic inflammatory effects. Aprotonin administration may increase systemic inflammation without significant contributions to neuroinflammation. While no antifibrinolytic medication improved systemic inflammation, these data suggest that TXA may provide the most beneficial inflammatory modulation after TBI.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ta.0000000000003607","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T09:42:53Z","timestamp":1648028573000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Effects of antifibrinolytics on systemic and cerebral inflammation after traumatic brain injury"],"prefix":"10.1097","volume":"93","author":[{"given":"Taylor E.","family":"Wallen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen E.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew R.","family":"Baucom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa G.","family":"England","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Pritts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"issue":"7","key":"bib1-20250806","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1089\/neu.2015.4039","article-title":"Time course of coagulation and fibrinolytic parameters in patients with traumatic brain injury","volume":"33","year":"2016","journal-title":"J Neurotrauma"},{"issue":"6","key":"bib2-20250806","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-019-0213-5","article-title":"Dissemination of brain inflammation in traumatic brain injury","volume":"16","year":"2019","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"bib3-20250806","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.neuron.2017.07.010","article-title":"Neuroimmunology of traumatic brain injury: time for a paradigm shift","volume":"95","year":"2017","journal-title":"Neuron"},{"issue":"6","key":"bib4-20250806","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/TA.0b013e318292cc54","article-title":"Tranexamic acid in trauma: how should we use it?","volume":"74","year":"2013","journal-title":"J Trauma Acute Care Surg"},{"issue":"7\u20138","key":"bib5-20250806","first-page":"873","article-title":"Novel aspects and new roles for the serine protease plasmin","volume":"61","year":"2004","journal-title":"Cell Mol Life Sci"},{"issue":"Suppl 1","key":"bib6-20250806","first-page":"132","article-title":"Fibrinolysis, inflammation, and regulation of the plasminogen activating system","volume":"5","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"10210","key":"bib7-20250806","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/S0140-6736(19)32233-0","article-title":"Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial","volume":"394","year":"2019","journal-title":"Lancet"},{"issue":"10","key":"bib8-20250806","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jama.2020.8958","article-title":"Effect of out-of-hospital tranexamic acid vs placebo on 6-month functional neurologic outcomes in patients with moderate or severe traumatic brain injury","volume":"324","year":"2020","journal-title":"JAMA"},{"key":"bib9-20250806","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-319-18497-5_54","article-title":"Epsilon aminocaproic acid pretreatment provides neuroprotection following surgically induced brain injury in a rat model","volume":"121","year":"2016","journal-title":"Acta Neurochir Suppl"},{"issue":"3\u20134","key":"bib10-20250806","first-page":"207","article-title":"Proteolytic enzyme activity in patients with severe head injury and the effect of a proteinase inhibitor","volume":"49","year":"1979","journal-title":"Acta Neurochir"},{"issue":"10","key":"bib11-20250806","first-page":"1","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","year":"2013","journal-title":"Health Technol Assess"},{"issue":"6","key":"bib12-20250806","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/1570159X14666160309123554","article-title":"Neuroprotection by estrogen and progesterone in traumatic brain injury and spinal cord injury","volume":"14","year":"2016","journal-title":"Curr Neuropharmacol"},{"key":"bib13-20250806","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jss.2019.06.023","article-title":"UCH-L1 is a poor serum biomarker of murine traumatic brain injury after polytrauma","volume":"244","year":"2019","journal-title":"J Surg Res"},{"key":"bib14-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jss.2019.06.022","article-title":"The role of chemoprophylactic agents in modulating platelet aggregability after traumatic brain injury","volume":"244","year":"2019","journal-title":"J Surg Res"},{"key":"bib15-20250806","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.thromres.2019.12.013","article-title":"Oxygenation extremes after traumatic brain injury transiently affect coagulation","volume":"186","year":"2020","journal-title":"Thromb Res"},{"issue":"2S Suppl 2","key":"bib16-20250806","first-page":"S89","article-title":"Postinjury treatments to make early tactical aeromedical evacuation practical for the brain after TBI","volume":"91","year":"2021","journal-title":"J Trauma Acute Care Surg"},{"key":"bib17-20250806","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jss.2017.03.031","article-title":"Impact of tranexamic acid on coagulation and inflammation in murine models of traumatic brain injury and hemorrhage","volume":"215","year":"2017","journal-title":"J Surg Res"},{"key":"bib18-20250806","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/s41598-019-52621-8","article-title":"Short-term inhibition of fibrinolytic system restores locomotor function after spinal cord injury in mice","volume":"9","year":"2019","journal-title":"Sci Rep"},{"issue":"19","key":"bib19-20250806","doi-asserted-by":"crossref","first-page":"E1132","DOI":"10.1097\/BRS.0000000000000488","article-title":"The effects of Amicar and TXA on lumbar spine fusion in an animal model","volume":"39","year":"2014","journal-title":"Spine (Phila Pa 1976)"},{"issue":"1","key":"bib20-20250806","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/oxfordjournals.ndt.a027062","article-title":"Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis","volume":"11","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"bib21-20250806","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jss.2010.05.055","article-title":"Hypobaric hypoxia exacerbates the neuroinflammatory response to traumatic brain injury","volume":"165","year":"2011","journal-title":"J Surg Res"},{"issue":"17","key":"bib22-20250806","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1089\/neu.2019.6436","article-title":"Acid sphingomyelinase inhibition mitigates histopathological and behavioral changes in a murine model of traumatic brain injury","volume":"37","year":"2020","journal-title":"J Neurotrauma"},{"issue":"9734","key":"bib23-20250806","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(10)60939-7","article-title":"Antifibrinolytic therapy: new data and new concepts","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"bib24-20250806","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1186\/s13054-014-0685-8","article-title":"Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial","volume":"18","year":"2014","journal-title":"Crit Care"},{"issue":"12","key":"bib25-20250806","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/jth.14316","article-title":"The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial","volume":"16","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"10","key":"bib26-20250806","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2019000092","article-title":"Tranexamic acid modulates the immune response and reduces postsurgical infection rates","volume":"3","year":"2019","journal-title":"Blood Adv"},{"key":"bib27-20250806","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13018-018-0855-5","article-title":"Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study","volume":"13","year":"2018","journal-title":"J Orthop Surg Res"},{"issue":"3","key":"bib28-20250806","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrneurol.2017.13","article-title":"The far-reaching scope of neuroinflammation after traumatic brain injury","volume":"13","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"bib29-20250806","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/neu.2009.1120","article-title":"In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury","volume":"27","year":"2010","journal-title":"J Neurotrauma"},{"issue":"1\u20132","key":"bib30-20250806","first-page":"57","article-title":"Anti-phospho-tau gene therapy for chronic traumatic encephalopathy","volume":"31","year":"2020","journal-title":"Hum Gene Ther"},{"key":"bib31-20250806","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2147\/JEP.S284532","article-title":"Tranexamic acid improves memory and learning abilities in aging mice","volume":"12","year":"2020","journal-title":"J Exp Pharmacol"},{"issue":"1","key":"bib32-20250806","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12974-019-1536-y","article-title":"Tranexamic acid reduces heme cytotoxicity via the TLR4\/TNF axis and ameliorates functional recovery after spinal cord injury","volume":"16","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"3","key":"bib33-20250806","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/ALN.0000000000001997","article-title":"Antifibrinolytic therapy and perioperative considerations","volume":"128","year":"2018","journal-title":"Anesthesiology"},{"key":"bib34-20250806","first-page":"41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"issue":"12","key":"bib35-20250806","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI63375","article-title":"Tranexamic acid concentrations associated with human seizures inhibit glycine receptors","volume":"122","year":"2012","journal-title":"J Clin Invest"},{"issue":"5","key":"bib36-20250806","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0022-5223(03)00946-2","article-title":"Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin","volume":"126","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"11","key":"bib37-20250806","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1161\/01.STR.0000033932.34467.97","article-title":"Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats","volume":"33","year":"2002","journal-title":"Stroke"},{"issue":"5","key":"bib38-20250806","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1227\/01.neu.0000303203.07866.18","article-title":"Matrix metalloproteinase inhibition attenuates brain edema in an in vivo model of surgically-induced brain injury","volume":"61","year":"2007","journal-title":"Neurosurgery"}],"container-title":["Journal of Trauma and Acute Care Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003607","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T16:18:42Z","timestamp":1754497122000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TA.0000000000003607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/ta.0000000000003607","relation":{},"ISSN":["2163-0763","2163-0755"],"issn-type":[{"value":"2163-0763","type":"electronic"},{"value":"2163-0755","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}